GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Intelligent Bio Solutions
Intelligent Bio Solutions offers rapid saliva-based drug tests. Its stock price is a bet on the adoption of this technology in workplaces and law enforcement. The timeline reflects the long road to widespread commercial adoption.
Share prices of companies in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops and markets rapid saliva tests that can quickly detect the presence of narcotics. We've categorized it as "Therapeutic Medical Equipment." The graph below shows the dynamics in the rapid and portable diagnostics sector.
Broad Market Index - GURU.Markets
Intelligent Bio Solutions is a company that provides portable diagnostic tests, specifically for saliva drug detection. As a significant player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with INBS performance to assess the state of this sector.
Change in the price of a company, segment, and market as a whole per day
INBS - Daily change in the company's share price Intelligent Bio Solutions
Intelligent Bio Solutions' daily share price fluctuations reflect the volatility of the rapid diagnostics sector. This metric measures the sensitivity to demand for its drug tests and other biomarkers, providing an indicator of market conditions.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Intelligent Bio Solutions Inc. is a medical diagnostics company. This chart shows the sector's high volatility. A comparison with INBS's performance, with its rapid testing, helps to assess it as an innovative player.
Daily change in the price of a broad market stock, index - GURU.Markets
Intelligent Bio Solutions produces rapid diagnostic tests, such as saliva-based drug screening. This innovative medtech company's shares are responding to commercial success and regulatory decisions. Its history reflects the medtech sector's contribution to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Intelligent Bio Solutions
Intelligent Bio Solutions' year-over-year performance is a story of commercializing its rapid drug testing solutions. Its 12-month market cap growth reflects its success in implementing its fingerprint-based system for rapid, non-invasive screening, which is used in the workplace and by law enforcement agencies.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Intelligent Bio, as a company developing rapid diagnostic tests, is betting on medical innovation. Its performance relative to the sector will determine how successfully its products compete in the market and how it is impacted by changes in demand for diagnostics after the pandemic.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Intelligent Bio Solutions, with its rapid saliva-based tests, is trying to change the world of diagnostics. Its performance relative to the market demonstrates how successfully it is commercializing its technology. Outperforming growth will mean widespread adoption of its tests in medicine and the workplace.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Intelligent Bio Solutions
Intelligent Bio Solutions provides rapid diagnostic tests. Its monthly performance reflects progress in commercializing its tests, such as saliva-based drug detection. News of regulatory approvals and contract awards are the main drivers.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops and markets rapid saliva drug detection tests that provide results in minutes. This is a convenient tool for employers and law enforcement agencies. The graph below shows the dynamics of the diagnostic equipment sector, where speed and ease of use are key advantages.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Intelligent Bio Solutions develops portable rapid diagnostic tests. Demand for its products may depend on specific testing needs (for example, workplace drug testing or viral detection). Share price performance is driven by the speed of commercialization and is independent of market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Intelligent Bio Solutions
Intelligent Bio Solutions develops rapid diagnostic tests. Its weekly stock price reflects demand for its products and news about the development of new tests, particularly in the context of public health.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Intelligent Bio Solutions offers rapid diagnostic tests. This chart compares the company's weekly stock performance with the medical device sector. Are the price fluctuations a reaction to news about new products and contracts, or is this a general trend in the diagnostics industry?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
As a medical technology company, Intelligent Bio Solutions should be less dependent on economic cycles. The chart will show how insulated the company's shares are from general market fluctuations, moving with product and contract news while ignoring macroeconomic noise.
Market capitalization of the company, segment and market as a whole
INBS - Market capitalization of the company Intelligent Bio Solutions
Intelligent Bio Solutions' market cap reflects the demand for rapid testing. The chart of the company, which developed a saliva drug test, shows how investors assess its commercial potential in markets where fast and non-invasive testing is important, such as in the workplace.
INBS - Share of the company's market capitalization Intelligent Bio Solutions within the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops and markets rapid saliva drug detection tests. Its market capitalization in the therapeutic and diagnostic equipment segment reflects its innovative approach. The company's market capitalization reflects demand for rapid, non-invasive tests from employers, law enforcement agencies, and healthcare institutions.
Market capitalization of the market segment - Therapeutic medical equipment
Intelligent Bio Solutions offers rapid fingerprint drug testing. How big is this industry? The chart below shows the overall market capitalization of the therapeutic device sector. Its dynamics reflect the need for innovative and non-invasive testing methods to ensure workplace safety.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Intelligent Bio Solutions chart shows how the market values rapid drug testing technology. The market capitalization of the company, which developed a saliva drug testing system, reflects its potential in the workplace and law enforcement markets. This diagram illustrates how speed and convenience of diagnostics create value.
Book value capitalization of the company, segment and market as a whole
INBS - Book value capitalization of the company Intelligent Bio Solutions
For Intelligent Bio Solutions, a developer of rapid saliva drug tests, the book value is its production capacity for test cartridges and readers. The chart below shows how the value of this diagnostic production base has changed.
INBS - Share of the company's book capitalization Intelligent Bio Solutions within the market segment - Therapeutic medical equipment
Intelligent Bio Solutions Inc. creates rapid diagnostic tests. Its tangible assets include production lines for its unique saliva-based test cartridges. These facilities provide the physical foundation for rapid and convenient diagnostics. The chart shows the share of this innovative production infrastructure the company controls.
Market segment balance sheet capitalization - Therapeutic medical equipment
Intelligent Bio Solutions produces drug testing systems. The medical equipment sector, as the chart shows, is capital-intensive. IBS is a classic player. Its business consists of R&D and factories that produce its unique portable tests.
Book value of all companies included in the broad market index - GURU.Markets
Intelligent Bio Solutions' assets include production facilities for a unique rapid drug test that analyzes saliva and provides results in minutes. The book value reflects the commercial potential of this convenient diagnostic tool.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Intelligent Bio Solutions
Intelligent Bio Solutions produces rapid saliva tests, including drug tests. Its value lies in its technology. The chart shows how the market perceives its growth potential in areas such as workplace safety and law enforcement.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops rapid and non-invasive diagnostic tests, such as sweat-based ones. Its value lies in its technology and patents. The chart shows how the market values its innovative testing platform compared to its tangible assets.
Market to book capitalization ratio for the market as a whole
Intelligent Bio Solutions offers rapid diagnostic tests. The company's value lies in its patented technology and speed to market. This chart illustrates how the market values innovation in medical technology, where intangible assets such as patents are the primary value driver.
Debts of the company, segment and market as a whole
INBS - Company debts Intelligent Bio Solutions
Intelligent Bio Solutions develops rapid and non-invasive testing systems, such as saliva-based drug testing. Commercializing diagnostic tests requires capital for production, regulatory approvals, and marketing. This chart illustrates how the company finances production scaling and expanding its technology into new markets.
Market segment debts - Therapeutic medical equipment
Intelligent Bio Solutions develops rapid and non-invasive diagnostic tests. Commercializing these products requires costs for production, marketing, and regulatory approval. This chart shows how the company finances its operations to achieve profitability in the competitive diagnostics market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Intelligent Bio Solutions
Intelligent Bio Solutions develops rapid diagnostic tests. This chart shows the financial structure of the medical diagnostics company. Debt may be justified if the company has a marketable product, but it is a risk if the company is still in the R&D and regulatory approval stages.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Intelligent Bio Solutions develops rapid, non-invasive tests, such as fingerprint-based drug detection. This market demands precision and regulatory approval. The chart shows the overall debt burden in the sector, providing context for assessing how the company finances its R&D and market entry with innovative diagnostic solutions.
Debt to book value of all companies in the market
Intelligent Bio Solutions provides rapid diagnostic tests, such as for drug testing. This business requires investment in R&D and production. This chart helps assess how the company finances its operations: whether it uses debt to scale production or relies on sales revenue and investor capital to develop new tests.
P/E of the company, segment and market as a whole
P/E - Intelligent Bio Solutions
This chart shows the valuation of Intelligent Bio Solutions, a company developing rapid diagnostic tests. The price-to-earnings ratio (if any) will reflect the demand for its diagnostic systems. This is a bet that fast and convenient diagnostics will become increasingly popular in various fields, from medicine to workplace monitoring.
P/E of the market segment - Therapeutic medical equipment
Intelligent Bio Solutions provides rapid and non-invasive fingerprint-based drug detection tests and develops biosensor technologies for other diagnostic applications. This chart shows the average rating for the sector, helping to understand how the market views this innovative and user-friendly testing platform.
P/E of the market as a whole
Intelligent Bio Solutions develops portable rapid diagnostic tests, such as saliva drug tests. Its valuation depends on the adoption of its technology by law enforcement and in the workplace. General market sentiment, reflected in this chart, has little impact on its business, which is driven by the need for rapid and accurate diagnostics.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Intelligent Bio Solutions
Intelligent Bio Solutions develops and markets rapid, non-invasive saliva drug detection tests. This chart shows expected growth in the workplace and law enforcement testing market. Future profitability depends on the adoption of its portable testing system and demand for more effective screening methods.
%20P%2FE%20Intelligent%20Bio%20Solutions&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Intelligent-Bio-Solutions&v=1772537158939 "Chart of the company's future (projected) P/E Intelligent Bio Solutions")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops rapid, non-invasive diagnostic tests, such as those based on saliva. Its valuation relative to other companies in the medical diagnostics sector reflects investor sentiment toward its technology platform. This demonstrates whether investors believe in the convenience and accuracy of its tests and their commercial potential.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772537159009 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Intelligent Bio Solutions develops rapid diagnostic tests, such as those based on saliva. The company's technologies could find application in medicine, the workplace, and law enforcement. This chart shows the overall sentiment in the healthcare market and helps assess how investors view diagnostic companies after the pandemic boom subsides.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772537159092 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Intelligent Bio Solutions
Intelligent Bio Solutions develops and markets rapid, non-invasive fingerprint-based drug detection tests. The financial results illustrated in this chart depend on the adoption of this technology in workplaces and other areas where drug testing is required.
Profit of companies in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops rapid, non-invasive diagnostic tests, such as those based on saliva. This chart shows the overall profitability of the therapeutic and diagnostic equipment sector. It helps understand how high the demand for rapid diagnostics is outside of pandemic scenarios and how profitable this market is.
Overall market profit
Intelligent Bio Solutions offers rapid, non-invasive drug detection tests. Demand for its products is driven by employers' and law enforcement agencies' employee testing needs. This market is less susceptible to economic cycles than others, as safety and regulatory compliance are always paramount.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Intelligent Bio Solutions
Intelligent Bio Solutions develops rapid and non-invasive diagnostic tests, including fingerprint-based drug testing. The company's future profitability depends on the market acceptance of its technology. This chart reflects analysts' expectations for demand for its innovative diagnostic systems from law enforcement agencies and employers.
%20profit%20of%20the%20company%20Intelligent%20Bio%20Solutions&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Intelligent-Bio-Solutions&v=1772537159365 "Graph of future (projected) profit of the company Intelligent Bio Solutions")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops and markets rapid, non-invasive saliva drug detection tests. These systems are designed for use in workplaces and law enforcement. This chart shows forecasts for the therapeutic medical device sector. It helps assess how the need for rapid and accurate testing is impacting growth in this segment.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772537159404 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
This graph shows the budgets of healthcare systems and corporations. For Intelligent Bio Solutions, a developer of rapid tests, this determines demand. Economic growth allows companies and healthcare institutions to invest in health monitoring systems. During recessions, such spending can be reduced.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772537159478 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Intelligent Bio Solutions
Intelligent Bio Solutions develops rapid diagnostic tests. This chart shows how investors view its early revenue and the potential for widespread adoption of its diagnostic systems in various fields, from medicine to the workplace.
P/S market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops and markets rapid diagnostic tests, including saliva drug testing. This chart shows the average valuation in the therapeutic medical devices sector. It helps understand how investors view the company's technology and its potential in the rapid and non-invasive diagnostics market.
P/S of the market as a whole
Intelligent Bio Solutions Inc. develops and markets rapid saliva drug detection tests. The system is fast and non-invasive. The company's revenue depends on demand from employers and law enforcement agencies. This chart helps assess how the market values a company with an innovative product in medical diagnostics.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Intelligent Bio Solutions
Intelligent Bio Solutions develops rapid diagnostic tests, such as those based on saliva. Future revenue depends on the commercialization and widespread adoption of its diagnostic platform. This chart shows how investors assess the rapid diagnostic market potential and the competitive advantages of the company's technology.
%20P%2FS%20Intelligent%20Bio%20Solutions&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Intelligent-Bio-Solutions&v=1772537159739 "The graph of the company's future (projected) P/S Intelligent Bio Solutions")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops and markets rapid, non-invasive saliva drug detection tests. This technology is suitable for workplace testing and law enforcement. This chart shows how the market assesses the sales potential of this innovative diagnostic system compared to other medical equipment.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772537159820 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
This chart shows general expectations for the rapid diagnostics market. For Intelligent Bio Solutions, a developer of sweat-based tests, this reflects demand for fast, non-invasive solutions. Market optimism supports the adoption of new technologies in corporate security and healthcare.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772537159852 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Intelligent Bio Solutions
Intelligent Bio Solutions develops and sells rapid drug detection tests for saliva. This chart shows revenue from sales of test cartridges and portable analyzers. Sales growth depends on the implementation of these systems in workplaces for employee screening and by law enforcement agencies for roadside enforcement.
Sales of companies in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops and markets rapid drug detection tests using saliva. This graph illustrates the growth of the therapeutic medical equipment market. The company's technology offers a fast, non-invasive, and accurate testing method, which is in demand in the workplace, law enforcement, and healthcare.
Overall market sales
Intelligent Bio Solutions Inc. provides rapid, non-invasive fingerprint drug detection tests. Demand for its products comes from employers and law enforcement agencies. The overall economic situation, illustrated in this graph, impacts the labor market and budgets of the organizations that are the company's primary clients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Intelligent Bio Solutions
Intelligent Bio Solutions develops portable rapid saliva tests, specifically for drug detection. These tests can be used in the workplace to screen employees. This chart shows analysts' forecasts for drug testing market growth and the adoption of the company's technology across various industries.
%20sales%20of%20the%20company%20Intelligent%20Bio%20Solutions&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Intelligent-Bio-Solutions&v=1772537160107 "Schedule of future (projected) sales of the company Intelligent Bio Solutions")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops rapid diagnostic tests, including saliva-based ones. This graph reflects expectations for the therapeutic medical device sector. It demonstrates the growing demand for fast and convenient diagnostic solutions that can be used outside the laboratory.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772537160270 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Intelligent Bio Solutions Inc. provides rapid, non-invasive fingerprint-based drug detection tests. Demand for its technology is driven by workplace and law enforcement testing needs. This trend, reflecting overall business activity, correlates with employment growth and the need to ensure workplace safety.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772537160360 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Intelligent Bio Solutions
Intelligent Bio Solutions develops rapid saliva tests. This chart shows the company's financial performance at the commercialization stage. Profitability depends on sales volumes of its diagnostic systems, such as those for workplace drug detection. Scaling production and sales is a key challenge.
Market segment marginality - Therapeutic medical equipment
Intelligent Bio Solutions develops portable systems for rapid saliva drug testing. Profitability in the diagnostic equipment sector depends on the accuracy, speed, and cost of tests. This graph shows the average profitability in the industry, allowing one to assess the competitiveness and market demand of the company's technology.
Market marginality as a whole
Intelligent Bio Solutions develops and sells rapid diagnostic tests, such as those based on saliva. This overall market profitability curve is not key for the company. Demand for its products depends on the need for fast and convenient testing in various sectors, from medicine to workplace monitoring. Its margins depend on production volumes and test accuracy.
Employees in the company, segment and market as a whole
Number of employees in the company Intelligent Bio Solutions
Intelligent Bio Solutions develops and markets rapid diagnostic tests, such as fingerprint drug testing. This graphic shows the small team focused on research, production, and commercialization of this innovative diagnostic platform.
Share of the company's employees Intelligent Bio Solutions within the market segment - Therapeutic medical equipment
Intelligent Bio Solutions develops rapid diagnostic tests, such as those based on saliva. This chart shows the percentage of biochemists, engineers, and production specialists the company employs in the rapid diagnostics sector. It reflects its ability to concentrate talent on creating simple and rapid diagnostic solutions.
Number of employees in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions is developing rapid and non-invasive diagnostic tests, such as those based on saliva. This could significantly simplify and speed up the testing process. This graph shows how the pandemic has spurred innovation in diagnostics, creating demand for new technologies and the specialists capable of developing and bringing them to market.
Number of employees in the market as a whole
Intelligent Bio Solutions offers rapid diagnostic tests, which has become especially relevant in recent years. This graph reflects the economy's ability to adapt to new challenges. The growth of companies in the rapid diagnostics sector, like IBS, demonstrates how innovation can quickly create a new market and, consequently, new jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Intelligent Bio Solutions (INBS)
Intelligent Bio Solutions provides rapid tests (e.g., saliva-based drug screening). This chart reflects the value of its intellectual capital. The company's main asset is its patented "biosensor platform" technology. The chart shows how highly the market values this unique and rapid diagnostic technology per employee developing and selling it.
%20of%20the%20company%20Intelligent%20Bio%20Solutions%20(INBS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Intelligent-Bio-Solutions-INBS&v=1772537160797 "Chart of market capitalization per employee (in thousands of dollars) of the company Intelligent Bio Solutions (INBS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions offers rapid diagnostic tests. In this business, technological precision and commercialization efficiency are crucial. The chart shows how the market evaluates the company's ability to monetize its developments. This industry comparison helps understand the competitiveness and demand for their products.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772537160853 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Intelligent Bio Solutions provides rapid and non-invasive diagnostic tests. This chart shows the average market value of each employee's contribution. It helps evaluate a company with innovative technology in medical diagnostics.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772537160880 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Intelligent Bio Solutions (INBS)
Intelligent Bio Solutions produces rapid drug testing kits (such as saliva-based drug tests). They manufacture and sell medical equipment. This chart shows how efficiently their production lines and sales team generate profit. It reflects the profit margin of their tests per employee.
%20Chart%20Intelligent%20Bio%20Solutions%20(INBS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Intelligent-Bio-Solutions-INBS&v=1772537160939 "Company Profit Per Employee (in thousands of dollars) Chart Intelligent Bio Solutions (INBS)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions offers rapid, non-invasive fingerprint drug detection tests. It's a technology company whose success depends on the accuracy of its product and the effectiveness of its sales team. This chart shows how successfully the company is monetizing its innovative technology, reflecting the financial return on each employee's sales and marketing efforts.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772537161007 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Intelligent Bio Solutions (INBS) (formerly GBS Inc.) is developing non-invasive rapid diagnostics, specifically a saliva glucose test (instead of a finger prick). It's an R&D MedTech business. This chart shows the general market standard for profitability per employee. For INBS (which is currently investing in R&D), this is a benchmark: if successful, their IP will generate high profitability per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772537161065 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Intelligent Bio Solutions (INBS)
Intelligent Bio Solutions develops and markets rapid diagnostic tests. This chart reflects performance in the medical diagnostics sector. It shows how successfully the company produces and markets its test systems, which enable rapid acquisition of important medical information.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Intelligent-Bio-Solutions-INBS&v=1772537161116 "Sales chart per company employee Intelligent Bio Solutions (INBS)")
Sales per employee in the market segment - Therapeutic medical equipment
Intelligent Bio Solutions (INBS) provides rapid, non-invasive tests (such as saliva) for diagnostics and screening. It's a medical technology company. This chart shows the average revenue per employee in the segment. It helps evaluate how effectively the INBS team (R&D, manufacturing, sales) commercializes its diagnostic solutions compared to competitors.
Sales per employee for the market as a whole
Intelligent Bio Solutions provides portable diagnostic tests (such as sweat drug tests). It's a medical technology company. This chart shows how efficiently their team (R&D, manufacturing, and sales) generates revenue from sales of their innovative, rapid diagnostic systems.
Short shares by company, segment and market as a whole
Shares shorted by company Intelligent Bio Solutions (INBS)
Intelligent Bio Solutions develops rapid diagnostic tests (based on saliva), including drug testing. This chart highlights concerns about their technology. Sellers may bet that their tests are insufficiently accurate or that the company will be unable to displace established testing methods (such as urine testing) from the market.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Intelligent-Bio-Solutions-INBS&v=1772537161272 "Short Shares Chart for the Company Intelligent Bio Solutions (INBS)")
Shares shorted by market segment - Therapeutic medical equipment
Intelligent Bio Solutions Inc. provides rapid, non-invasive saliva-based drug detection tests used by employers to screen employees. This chart shows the overall bearish sentiment in the therapeutics and diagnostics sector. A rising indicator may indicate that investors are hesitant about the widespread adoption of new testing methods.
Shares shorted by the overall market
Intelligent Bio Solutions is developing non-invasive diagnostic tests, such as sweat tests. It's a promising medical technology, but the company is still struggling to commercialize. This chart illustrates the general level of fear. When investors are afraid, they don't want to wait for FDA approvals. They sell off shares of small medical technology companies like INBS, fearing their high capital requirements.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Intelligent Bio Solutions (INBS)
Intelligent Bio Solutions offers rapid, non-invasive tests (for example, saliva-based), which are critical for the workplace. The diagnostics market is highly competitive. This indicator tracks how investors react to news of commercialization or approvals, showing "overheating" (above 70) on positive news or "oversold" (below 30) amid competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Intelligent-Bio-Solutions-INBS&v=1772537161553 "RSI 14 indicator chart for the company's stock Intelligent Bio Solutions (INBS)")
RSI 14 Market Segment - Therapeutic medical equipment
Intelligent Bio Solutions develops and commercializes non-invasive diagnostic tests. Their key technology is a fingerprint reader that can detect drugs and other substances in sweat. This chart reflects the overall health of the diagnostic equipment sector. It helps investors assess whether the entire industry is under pressure or, conversely, overbought amid new regulatory approvals.
RSI 14 for the overall market
For Intelligent Bio Solutions, a biotech company in the R&D stage, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast INBS (Intelligent Bio Solutions)
Intelligent Bio Solutions provides rapid saliva-based diagnostic tests, primarily for workplace drug testing. This chart shows the analysts' average 12-month forecast. It reflects their view on demand for these tests and competition in the diagnostics sector.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-INBS-Intelligent-Bio-Solutions&v=1772537161703 "A chart showing analyst consensus forecasts for the expected stock price. INBS (Intelligent Bio Solutions)")
The difference between the consensus estimate and the actual stock price INBS (Intelligent Bio Solutions)
Intelligent Bio Solutions is a company that provides rapid, non-invasive saliva-based drug detection tests for workplaces. This chart shows the upside and downside potential analysts see for the stock. It measures the gap between the price and forecast, reflecting their belief in the "safety testing" market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-INBS-Intelligent-Bio-Solutions&v=1772537161728 "A chart showing the difference between the consensus forecast and the actual stock price. INBS (Intelligent Bio Solutions)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Intelligent Bio Solutions is "drug testing 2.0." The company produces a 5-minute saliva-based rapid test for quick on-site testing. This chart reflects analysts' overall expectations for the entire medical device sector. It shows whether experts believe the rapid diagnostics market will grow.
Analysts' consensus forecast for the overall market share price
Intelligent Bio Solutions is developing a noninvasive saliva-based biosensor for rapid diagnostics—from drug testing to glucose monitoring. This graph shows the overall "risk appetite" in the market. For INBS, a company with an innovative but not yet commercialized technology, overall market optimism (risk appetite) is critical for R&D funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Intelligent Bio Solutions
Intelligent Bio Solutions (INBS) is an on-site diagnostician. Their signature feature is a smart saliva-based test system that instantly (in minutes) detects the presence of drugs or (potentially) viruses right at the workplace. This graph summarizes their implementation history, reflecting their (slow) progress in convincing companies to use their rapid test.
AKIMA Market Segment Index - Therapeutic medical equipment
Intelligent Bio Solutions (INBS) provides rapid, non-invasive diagnostic solutions. Their flagship product is a fingerprint drug test for use in the workplace. The chart shows the average index for the segment, helping investors assess the demand for this unique technology compared to the average.
The AKIM Index for the overall market
Intelligent Bio Solutions is a medtech company offering non-invasive fingerprint-based drug testing. It's fast and hygienic. This chart, reflecting the market average, is just a backdrop. It helps assess how INBS, a workplace safety solution, compares to overall macroeconomic trends.
